Dmitri Bobilev
Chief Tech/Sci/R&D Officer at FUSN PHAR
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Amanda Cray | F | - | - | |
| Christopher Leamon | M | 57 | 3 years | |
| Eric S. Hoffman | M | 54 | 3 years | |
| Maria D. Stahl | F | 53 | 4 years | |
| Eric Burak | M | - | 7 years | |
| Cara Ferreira | M | - | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kevin Coveney | M | 60 |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 2 years |
| John Valliant | M | 54 | 10 years | |
| Barbara Duncan | F | 59 | 4 years | |
| Philina Lee | M | 47 | 3 years | |
| Donald Bergstrom | M | 52 | 3 years | |
| Pablo Cagnoni | M | 60 | 5 years | |
| Steven Gannon | M | 62 | 4 years | |
| Johan Rutger Christenson | M | 65 | 6 years | |
| Chau Khuong | M | 48 | 4 years | |
| Heather Elizabeth Preston | M | 58 | 4 years | |
| Jeremy Bender | M | 52 | 1 years | |
| Justin Chakma | M | 35 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 1 years |
| John Crowley | M | 51 | 5 years | |
| Bruce Roberts | M | - |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | 4 years |
| Teresa Bitetti | F | - | 1 years | |
| Mohit Rawat | M | - | 3 years | |
| David Meek | M | 59 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 20 | 86.96% |
| United States | 3 | 13.04% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dmitri Bobilev
- Personal Network
